Parameswaran Hari, MD, MRCP, MS of Medical College of Wisconsin discusses the recent trend of immunotherapy in transplantation in myeloma…
Browsing: Acute Lymphoblastic Leukemia
Parameswaran Hari, MD, MRCP, MS of Medical College of Wisconsin discusses a new standard of care for newly diagnosed myeloma…
Parameswaran Hari, MD, MRCP, MS of Medical College of Wisconsin gives an overview of the results and aftermath of Phase…
Alok Khorana, MD of Cleveland discusses the importance of assessing for risks of clots and bleeding before administering medication at…
Alok Khorana, MD of Cleveland Clinic discusses how new and important data on direct oral anticoagulants, which is widely used…
Alok Khorana, MD of Cleveland Clinic, discusses how recent funding for thromboprophylaxis may lead to a clinical trial that will…
Alok Khorana, MD of Cleveland Clinic discusses the recent transition from injectable anticoagulants, which is sometimes difficult to manage, to…
Is interferon or hydroxyurea (Hydrea) more effective as a treatment for polycythemia vera (PV)? MPN expert and researcher, Dr. Heinz…
Can CML patients responding positively to therapy have their medications safely reduced? CML expert Dr. Mhairi Copland of the University…
Alok Khorana, MD of Cleveland Clinic discusses a cohort study that focused on bleeding predictors in hospitalized cancer patients at…
Sudipto Mukherjee, MD, MPH of Cleveland Clinic discusses several and recent developments in AML treatment at the 58th ASH Annual…
Sudipto Mukherjee, MD, MPH of Cleveland Clinic discusses how the new drug, eltrombopag, works safely and more effectively for patients…
Sudipto Mukherjee, MD, MPH of Cleveland Clinic gives an overview of his abstract: A Single Arm, Phase II Study of…
Brian Hill, MD, PhD of Cleveland Clinic discusses the possibility of a combination between checkpoint inhibitors and CAR T-Cell therapy…
Brian Hill, MD, PhD of Cleveland Clinic discusses the important role of checkpoint inhibitors in Richter’s Transformation treatment at the…
Brian Hill, MD, PhD of Cleveland Clinic, gives an overview of the updates surrounding CLL treatments, specifically how CAR T-Cell…
Brian Hill, MD, PhD, of Cleveland Clinic discusses how Venetoclax may be the best novel agent for patients who are…
Brian Hill, MD, PhD, of Cleveland Clinic discusses updates surrounding CLL, specifically responses to Ibrutinib and Venetoclax as the optimal…
Navneet Majhail, MD of Cleveland Clinic, discusses how TP53 mutations lead to poor overall survival in patients with MDS at…
Navneet Majhail, MD, of Cleveland Clinic, discusses the importance of genetic alterations and mutation profiles of patients that are undergoing…
Navneet Majhail, MD of Cleveland Clinic, gives an overview of Abstract 69: Genetic Alterations Predict Outcomes in Patients with Myelodysplastic…
Jasmine Micklem, PhD, of the South Australian Health and Medical Research Institute, Adelaide, Australia, and Roslyn Weetra, an Aboriginal Elder…
Bernardo Rapoport, MD of The Medical Oncology Centre of Rosebank, Johannesburg, South Africa discusses side effects associated with different types…
Charles Kamen, PhD of University of Rochester Medical Center, Rochester, NY discusses the impact of dyadic exercises on cancer patients.…
Jennifer Brown, MD of Dana Farber, discusses a current and promising trial that combines ibrutinib with a standard chemo-immunotherapy combination:…
Jennifer Brown, MD of Dana Farber, discusses a promising study that combines Ibrutinib with TGR-1202 and its results at the…
Jennifer Brown, MD of Dana Farber, discusses the update of the 5 year data from the Ibrutinib study at the…
Jennifer Brown, MD of Dana Farber, gives an overview of the latest treatment trends for CLL for the upcoming year…
Jennifer Brown, MD of Dana Farber discusses the updates of CAR T-Cell Therapy in CLL from the 58th ASH Annual…
Steven T. Rosen, MD of City of Hope, discusses the use of novel strategies for stem cell efficacy versus its…
Steven T. Rosen, MD of City of Hope, discusses the potential of leflunomide for multiple myeloma at the 58th ASH…
Steven T. Rosen, MD of City of Hope, gives an overview of the current trials on stem cell research for…
Susan M. O’Brien, MD of University of California Irvine, discusses the future of clinical trials for ibrutinib that may result…
Susan M. O’Brien, MD of University of California Irvine, discusses possible drug holidays and combination therapy for CLL at the…
Susan M. O’Brien, MD of University of California Irvine gives an overview of the updates in combination therapy for CLL…
Joshua Brody, MD, PhD, of Mount Sinai Hospital, gives a shoutout to his grandma and grandpa at the 58th ASH…
Joshua Brody, MD, PhD of Mount Sinai Hospital, discusses how to rationally combine immunotherapies for patients with lymphoma by increasing…
Joshua Brody, MD, PhD of Mount Sinai Hospital, discusses the GALLIUM Trial and advances in immunotherapy for lymphoma at the…
Joshua Brody, MD, PhD, of Mount Sinai Hospital, gives an update on CAR T-Cell Lymphoma data from the 58th ASH…
Joshua Brody, MD, PhD, of Mount Sinai Hospital, discusses how animal studies closely resemble clinical trial results in combining in…
Joshua Brody, MD, PhD, of Mount Sinai Hospital, discusses his abstract on Combining In Situ Vaccination with Immune Checkpoint Blockade…
Joshua Brody, MD, PhD, of Mount Sinai Hospital, gives an overview of a clinical trial by Dana Farber that shows…
Peter Hillmen from St. James University Hospital, Leeds, UK introduces the 17th International Workshop on chronic lymphocytic leukemia (iwCLL), which…
Stephen Sonis, DMD, DMSc of Brigham and Women’s Hospital, Boston, MA discusses costs of cancer care. The cost of new…
Michael Brown, MBBS, FRACP, FRCPA of Royal Adelaide Hospital, Adelaide, Australia discusses global immune checkpoint inhibitor studies. Prof Brown mentions…
Jervoise Andreyev, MA, PhD, FRCP of The Royal Marsden NHS Foundation Trust, London, United Kingdom talks about MASCC discussions focused…
Jasmine Micklem, PhD, of the South Australian Health and Medical Research Institute, Adelaide, Australia, discusses disparities in the incidence of…
Bernardo Rapoport, MD and Ronwyn Van Eeden MBChB, FCP(SA) of The Medical Oncology Centre of Rosebank, Johannesburg, South Africa talk…
Meera Agar, MBBS, MPC, FRACP, PhD of University of Technology Sydney, Sydney, Australia discusses delirium treatment options. The guidelines internationally…
Matthew Ciorba, MD of Washington University School of Medicine in St. Louis, St. Louis, MO discusses how to use probiotics…